Abolition Of Man Essay -- essays research papers

Every culture ever known has operated under a system of values. Many varied on exact principles, but most applied the idea of Natural Law. Or, as C.S. Lewis would refer to it in his Abolition of Man, the Tao. In this particular book Lewis discusses the implications that would follow could man overcome this basic value system that has been in place since the development of rational thought. However, paradoxical as his opinion may seem, he holds that to step beyond the Tao is to plunge into nothingness. Simply put, it is his claim that to destroy, or even fundamentally change, man’s basic value system is to destroy man himself.   Ã‚  Ã‚  Ã‚  Ã‚  Lewis states late in the book that, â€Å"They are not men at all. Stepping outside the Tao, they have stepped into the void(64).† The empty â€Å"they† that Lewis is referring to those that would seek to move beyond the Tao. Acceptance in the belief that the Tao is the rational contents of everyman, which Lewis asserts openly in the text, is to say that he has moved beyond all that makes him man. Although the idea of overcoming the Tao leading to nothingness in man is somewhat abstract, Lewis explains it in different terms later. He discusses the qualitative value of things be saying, â€Å"It is not the greatest of modern scientists who feel most sure that the object, stripped of its qualitative properties and reduced to mere quantity, is wholly real(70).† This is to say that it is the Tao that gives man his qualitative properties and ...

The Various Government Roles In Health Care

In this new report MGI finds that the United States spends approximately $480 billion ($1,600 per capita) more on health care than other OECD countries and that additional spending is not explained by a higher disease burden; the research shows that the US population is not significantly sicker than the other countries studied. (www. mckinsey. com) Robert Frank, a Cornell economist, has proposed new ways of overcome the opposition to some kind of government- (and therefore taxpayers-), funded solution to the problem.He has put his finger on the two main obstacles to major change in the current system, insurance company opposition and higher taxes. He suggests that insurance companies, who have acted in good faith to respond to incentives provided by the market, could be subsidized for their losses while their managements shift their health insurance strategies, perhaps to provide only supplemental private coverage. A portion of the $280 billion in annual savings suggested above could be used for this purpose. (www. hbswk. hbs. edu/item/5645)Booz Allen Hamilton recently sponsored a panel discussion on â€Å"The Federal Government's Role in Medical Innovation. † The panel focused on federal programs, regulations and policies that can reduce barriers and foster innovation in healthcare delivery and medical product development in the United States. Participating on the panel and in the audience discussion were leading experts from payer, provider, and life science companies in the biotechnology and pharmaceutical sectors, as well as key policy makers and staff from government agencies.While participants acknowledged the challenges, they agree that government should play a continuing role—and, in some instances, a strengthened role—in promoting innovation in several key areas. (www. boozallen. com) Providing targeted funding to support development of product and service innovation at junctures where private funding is inadequate. Also with the f acilitating collaboration by setting standards for information exchange and leading selected cross- sector initiatives.And with the developments of regulations and policies that incentivize innovation and promote the dissemination and widespread use of models, technology, and products that demonstrate measurable gains in healthcare quality, efficiency and outcomes. (www. hbswk. hbs. edu/item/5645) The real bottom line is that the government is trying to cut billions of dollars from the federal government’s spending bill and healthcare is one of the leading costs for the government funding.The insurance companies, who have respond to incentives provided by the market, subsidize for their losses while their managements shift their health insurance strategies, perhaps to provide only supplemental private coverage. without the out front cost labeled as new taxes for the American citizens so it is being curved by the new healthcare plan that all Americans families must buy into to receive healthcare that is labeled as affordable, but to many Americans at is add cost that we just cannot afford with today economy. This would be a saving of $280 billion in annual that could be used for other purposes. The Various Government Roles in Health Care In this new report MGI finds that the United States spends approximately $480 billion ($1,600 per capita) more on health care than other OECD countries and that additional spending is not explained by a higher disease burden; the research shows that the US population is not significantly sicker than the other countries studied.Robert Frank, a Cornell economist, has proposed new ways of overcome the opposition to some kind of government- (and therefore taxpayers-), funded solution to the problem. He has put his finger on the two main obstacles to major change in the current system, insurance company opposition and higher taxes.He suggests that insurance companies, who have acted in good faith to respond to incentives provided by the market, could be subsidized for their losses while their managements shift their health insurance strategies, perhaps to provide only supplemental private coverage. A portion of the $280 billion in annual savings suggested above could be used for this purp ose.Booz Allen Hamilton recently sponsored a panel discussion on â€Å"The Federal Government's Role in Medical Innovation.† The panel focused on federal programs, regulations and policies that can reduce barriers and foster innovation in healthcare delivery and medical product development in the United States.Participating on the panel and in the audience discussion were leading experts from payer, provider, and life science companies in the biotechnology and pharmaceutical sectors, as well as key policy makers and staff from government agencies. While participants acknowledged the challenges, they agree that government should play a continuing role—and, in some instances, a strengthened role—in promoting innovation in several key areas.Providing targeted funding to support development of product and service innovation at junctures where private funding is inadequate. Also with the facilitating collaboration by setting standards for information exchange and lea ding selected cross- sector initiatives. And with the developments of  regulations and policies that incentivize innovation and promote the dissemination and widespread use of models, technology, and products that demonstrate measurable gains in healthcare quality, efficiency and outcomes.The real bottom line is that the government is trying to cut billions of dollars from the federal government’s spending bill and healthcare is one of the leading costs for the government funding. The insurance companies, who have respond to incentives provided by the market, subsidize for their losses while their managements shift their health insurance strategies, perhaps to provide only supplemental private coverage.Without the out front cost labeled as new taxes for the American citizens so it is being curved by the new healthcare plan that all Americans families must buy into to receive healthcare that is labeled as affordable, but to many Americans at is add cost that we just cannot a fford with today economy. This would be a saving of $280 billion in annual that could be used for other purposes.

The Legal Status Of Marijuana - 1087 Words

Furthermore, there are other articles that gave reliable information about the legal status of marijuana. This is important to know because legal ramifications is a very important aspect of the topic. These sources give information pertaining where it is legal and why it is not legal in other states. The article from www.ncbi.nlm.nih.gov divulged into the legal status. This thoroughly explained how the FDA currently does not approve the drug due to lack of scientific research. It also explained how and why the drug became Schedule 1. Finally, medscape.com contains details about the ethics of the topic. Medscape shows both sides of the story, which is more reliable than other sites that are too one sided. Medscape explained that those who†¦show more content†¦First, I went onto procon.org to get some background information on medical marijuana. I learned that there were many facets to this topic. There were legal, ethical, and medical dilemmas with legalizing medical marijuana. I also discovered that many states already have the substance legalized. Another article where I found good background info about the risks, benefits, uses, and certification was â€Å"Medical Marijuana† by Amy E. Thompson. After gaining some basic knowledge there were a few questions that I knew I wanted to answer. I wanted learn things like what doctor’s opinions were, where was it legalized, and why the FDA and federal government has not approved it. In order to do so, I decided to find my answers by scouring reli able websites and articles. I visited informational websites such as medscape.com, ncbi.nlm.nih.gov, drugpolicy.org,drugabuse.gov, www.fda.gov, and jama.jamanetwork.com. Each website contained articles about the various legal, ethical, and medical aspects. From this, I learned vital information about the topic and was able to make my decision. Findings: From the intense research the information learned included various doctor’s opinions, the government’s opinions, legalization, medical benefits, medical risks, and legal issues. First, the opinions of doctors are split because some support the idea while others oppose it. In both opinions, the doctor believes he